文献速递神经肿瘤

降低胶质瘤患者重复开颅术并发症发生率:单术者经验及与文献比较

Reducing complication rates for repeat craniotomies in glioma patients: a single-surgeon experience and comparison with the literature.
PubMed 文献 · Acta Neurochir (Wien) · 2021-12-30

该回顾性研究纳入2012至2019年由同一资深术者手术的714例WHO II-IV级胶质瘤患者,比较初次与重复开颅术的并发症谱。结果显示并发症、再手术率及新发神经功能缺损不因既往开颅次数而异;多因素分析中高龄(OR 1.5,95%CI 1.0-2.2)和类固醇所致显著白细胞增多(OR 12.6,95%CI 2.5-62.9)为并发症预测因素。队列并发症率低于文献报道,作者认为实施最佳实践时重复开颅术可与初次手术同样安全。

要点

  • 重复开颅术的并发症、再手术率及新发神经功能缺损与初次开颅术无差异。
  • 高龄(OR 1.5,95%CI 1.0-2.2)和类固醇所致显著白细胞增多(OR 12.6,95%CI 2.5-62.9)预测并发症。
  • 本队列并发症率低于文献报道,作者认为实施最佳实践时重复开颅术可与初次手术同样安全。

核心结论

  • 与既往文献报道相反,若术者实施最佳实践,重复开颅术可与初次手术同样安全。

研究设计与样本

  • 回顾性研究纳入2012年至2019年由同一资深术者手术的WHO II-IV级胶质瘤患者714例,按既往开颅次数分组并比较并发症。
  • 并发症记录至出院、术后30天和90天,新发神经功能缺损记录至术后90天;采用多因素回归分析并发症相关因素。
  • 另进行Meta分析,依据既往开颅次数识别并发症发生率。

主要发现

  • 714例中400例(56%)无既往开颅术,218例(30.5%)有1次既往开颅术,96例(13.5%)有≥2次既往开颅术。
  • 30例(4.2%)发生27例次手术并发症和10例次内科并发症,19例(2.7%)因并发症再手术,90天内无死亡。
  • 并发症、再手术率及新发神经功能缺损不因既往开颅次数而异。
  • 多因素分析中,高龄(OR 1.5,95%CI 1.0-2.2)和类固醇所致显著白细胞增多(OR 12.6,95%CI 2.5-62.9)为并发症预测因素。
  • 本队列并发症率低于文献报道的发生率。

临床怎么用

  • 作者认为,若术者实施最佳实践,重复开颅术可与初次手术同样安全。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a concern that glioma patients undergoing repeat craniotomies are more prone to complications. The study's goal was to assess if the complication profiles for initial and repeat craniotomies were similar, to determine predictors of complications, and to compare results with those in the literature. METHODS: A retrospective study was conducted of glioma patients (WHO grade II-IV) who underwent either an initial or repeat craniotomy performed by the senior author from 2012 until 2019. Complications were recorded by discharge, 30 days, and 90 days postoperatively. New neurologic deficits were recorded by 90 days postoperatively. Multivariate regression was performed to identify factors associated with complications. A meta-analysis was performed to identify rates of complications based on number of prior craniotomies. RESULTS: Within the cohort of 714 patients, 400 (56%) had no prior craniotomies, 218 (30.5%) had undergone 1 prior craniotomy, and 96 (13.5%) had undergone ≥ 2 prior craniotomies. There were 27 surgical and 10 medical complications in 30 patients (4.2%) and 19 reoperations for complications in 19 patients (2.7%) with no deaths by 90 days. Complications, reoperation rates, and new neurologic deficits did not differ based on number of prior craniotomies. On multivariate analysis, older age (OR1.5, 95%CI 1.0-2.2) and significant leukocytosis due to steroid use (OR12.6, 95%CI 2.5-62.9) were predictors of complications. Complication rates in the cohort were lower than rates reported in the literature. CONCLUSION: Contrary to prior reports in the literature, repeat craniotomies can be as safe as initial operations if surgeons implement best practices.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Morshed RA, Young JS, Gogos AJ, et al. Reducing complication rates for repeat craniotomies in glioma patients: a single-surgeon experience and comparison with the literature. Acta Neurochir (Wien). 2021. PMID: 34970702. doi:10.1007/s00701-021-05067-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。